DexCom Inc (DXCM)

Current ratio

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Total current assets	US$ in thousands	4,301,400	4,262,800	4,848,400	4,620,700	4,425,900	4,698,400	5,002,900	3,767,400	3,668,800	3,398,500	3,808,700	3,746,600	3,684,400	3,656,200	3,474,200	3,445,100	3,424,800	3,237,100	3,033,000	1,995,700
Total current liabilities	US$ in thousands	2,932,000	1,734,500	1,722,200	1,594,200	1,556,000	1,678,600	2,069,700	1,865,000	1,839,300	900,500	807,000	711,400	720,800	734,900	600,700	604,100	614,100	506,400	400,100	342,800
Current ratio		1.47	2.46	2.82	2.90	2.84	2.80	2.42	2.02	1.99	3.77	4.72	5.27	5.11	4.98	5.78	5.70	5.58	6.39	7.58	5.82

December 31, 2024 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $4,301,400K ÷ $2,932,000K
= 1.47

The current ratio of DexCom Inc, a measure of its short-term liquidity and ability to cover its current liabilities with current assets, has exhibited some fluctuations over the past few years. From March 31, 2020, to December 31, 2020, the current ratio ranged between 5.58 and 7.58, indicating a strong liquidity position during this period.

However, from March 31, 2021, to June 30, 2022, the current ratio decreased gradually, though remaining above 4.00, suggesting the company still had a comfortable liquidity position. Notably, the current ratio dropped below 4.00 from September 30, 2022, to December 31, 2023, which may indicate a potential liquidity concern during this period.

Subsequently, from March 31, 2024, to December 31, 2024, the current ratio ranged from 1.47 to 2.90, showing some improvement compared to the previous quarters but remaining below the levels seen in earlier periods. This trend could indicate varying levels of liquidity challenges or shifts in the company's current asset and liability composition.

Overall, while DexCom Inc has maintained a generally adequate current ratio above 2.00, it experienced some fluctuations in its liquidity position over the reviewed periods, warranting further analysis to understand the driving factors behind these changes.